Procure Proton Therapy Center First in World to Use Inclined Beam Technology

OKC center opens third cancer treatment room

OKLAHOMA CITY--(BUSINESS WIRE)-- The world’s first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer. The precision of proton therapy spares healthy tissue and results in far fewer short- and long-term treatment side effects. With three rooms now open and one more opening in the next few months, the Center is on its way to being able to provide the benefits of proton therapy to approximately 1,500 patients a year.

The newest treatment room is the first in the world to use inclined beam technology, a highly efficient and effective technological advance developed by scientists at ProCure Treatment Centers, Inc. The inclined beam technology is the first room to contain two treatment beams; one horizontal and one 60 degrees inclined from the horizontal. It can treat approximately 80 percent of the tumors that normally require the use of a gantry, the industry standard treatment room, but in a space about 50 percent of the size.

“We are committed to providing proton therapy to more patients and offering the best cancer care possible,” said Sameer Keole, M.D., medical director of the Center and radiation oncologist at Radiation Medicine Associates (RMA), the radiation oncology practice that provides clinical care at the Center. “We are especially proud to have the world’s first inclined beam room here in our facility. It is an important technological advance.”

“ProCure is dedicated to improving proton therapy technology by making advances like the inclined beam technology available in our centers, as well as offering it to other centers that will be opening,” said John Cameron, Ph.D., founder and president of ProCure and part of the inclined beam research and development team. “Our sole focus is on providing exceptional patient care.”

The Oklahoma City Center opened in 2009 and is treating patients diagnosed with a broad range of tumor types including head and neck, brain, central nervous system, prostate, lung, sarcomas, gastrointestinal and many pediatric cancers. The precision of proton therapy makes it especially effective for treating anatomically complex tumors such base of skull and tumors along the spinal cord.

The Center has an affiliation with INTEGRIS Health, the state's largest hospital system. INTEGRIS's new, state-of-the art Cancer Institute of Oklahoma, located adjacent to the ProCure Proton Therapy Center, provides patients with additional medical services that they may need while undergoing proton therapy.

The ProCure Proton Therapy Center in Oklahoma City is one of seven centers in the country currently providing proton therapy and the first in a network of ProCure centers. Additional ProCure Centers are under construction in suburban Chicago (Warrenville), scheduled to open in early 2011; and metro-New York (Somerset, N.J.), expected to open in 2012. ProCure also has centers in development in Seattle, Detroit and South Florida.

To learn more about proton therapy and the ProCure Proton Therapy Center in Oklahoma visit procure.com/ok or call 866-475-1285.

ABOUT PROCURE TREATMENT CENTERS, INC.

ProCure Treatment Centers, Inc. is a privately held health care company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. The company was founded in 2005 in Bloomington, Ind., and is the first to develop a network of proton therapy centers in cities across the United States. Its first center, the ProCure Proton Therapy Center in Oklahoma City, opened in 2009. Centers are under construction in Warrenville, Ill. and Somerset, N.J.; and others are in development in Seattle, Detroit and South Florida. ProCure provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of proton therapy centers. ProCure’s solution reduces the time, cost and effort necessary to build and operate a facility. ProCure is advancing proton therapy by collaborating with radiation oncology practices and hospitals to develop centers, through innovation and improvements in technology, and by providing training at the world’s only educational facility specializing in proton therapy. For more information, visit procure.com.

ABOUT RADIATION MEDICINE ASSOCIATES (RMA)

Radiation Medicine Associates, a leading radiation oncology practice in Oklahoma City, is bringing proton therapy, the most advanced external radiation therapy treatment, to Oklahoma City. They are well known and respected clinical physicians with a long history of clinical excellence. The doctors practice at the leading institutions in the area and have pioneered the newest and most appropriate cancer treatment technologies in the community. The physicians are longstanding members of the Oklahoma community who have dedicated their professional lives to the improvement of cancer treatment.

ABOUT INTEGRIS HEALTH

INTEGRIS Health is the state's largest Oklahoma-owned not-for-profit healthcare corporation, with hospitals, rehabilitation centers, physician clinics, mental health facilities, fitness centers, independent living centers and home health agencies throughout much of the state. Through its affiliates, INTEGRIS Health operates 13 hospitals, led in the Oklahoma City area by INTEGRIS Baptist Medical Center and INTEGRIS Southwest Medical Center. The organization has affiliated mental health providers in 50 Oklahoma towns and cities, and offers hospice services through Hospice of Oklahoma County. For more information, visit www.integris-health.com.



CONTACT:

for ProCure Treatment Centers, Inc.
Tim LeRoy, 312-558-1770
[email protected]

KEYWORDS:   United States  North America  Oklahoma

INDUSTRY KEYWORDS:   Health  Hospitals  Medical Devices  Oncology  Radiology

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.